Intensity Therapeutics, Inc. (INTS)
6.40
+0.56
(+9.59%)
USD |
NASDAQ |
Feb 24, 12:46
Intensity Therapeutics Market Cap : 384.42M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.197B |
| Alnylam Pharmaceuticals, Inc. | 43.77B |
| Savara, Inc. | 1.173B |
| BioMarin Pharmaceutical, Inc. | 12.17B |
| Imunon, Inc. | 6.790M |
Market Cap Related Metrics
| PEG Ratio | -0.0008 |
| Price to Book Value | 53.23 |
| Price | 6.40 |
| Earnings Yield | -165.2% |
| PEGY Ratio | -0.0008 |